About: covid:PMC7261209

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: covid:PMC7261209 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
Creator	von Lilienfeld-Toal, Marie Hochhaus, Andreas Koschmieder, Steffen Palandri, Francesca Rachow, Tobias Döhner, Konstanze Auteri, Guiseppe Brioli, Annamaria Crodel, Carl Ernst, Philipp Griesshammer, Martin Heidel, Florian Hofmann, Verena Isfort, Susanne Jentsch-Ullrich, Kathleen Jilg, Stefanie Jost, Philipp Kämpfe, Dietrich Stegelmann, Frank Wolleschak, Denise
is schema:about of	named entity 'Frequency' named entity 'patient-reported' named entity 'hydroxyurea' named entity 'hematology' named entity 'viral infections' named entity 'hepatitis' named entity 'viral infection' named entity '0.01' named entity 'antibiotics' named entity 'toxoplasmosis' named entity 'Germany' named entity 'interferons' named entity 'herpes zoster' named entity 'combination therapies' named entity 'meningococci' named entity 'RUX' named entity 'RUX' named entity 'bivariate analysis' named entity 'pneumococci' named entity 'Europe' named entity 'prophylactic' named entity '0.01' named entity 'patient-reported' named entity 'opportunistic infections' named entity 'MPN' named entity 'higher risk' named entity 'antiviral' named entity 'ruxolitinib' named entity 'Janus kinase (JAK) inhibitor' named entity 'MPN' named entity 'prophylaxis' named entity 'multivariate analysis' named entity '69.8%' named entity 'myelofibrosis' named entity 'MPN' named entity 'phenotype' named entity 'treatment options' named entity 'MPL' named entity 'heterogeneity' named entity 'MPN' named entity 'inflammatory' named entity 'MPN' named entity 'RUX' named entity 'pharmacologic treatment' named entity 'MPN' named entity 'vaccination' named entity 'MPN' named entity 'vaccines' named entity 'prophylaxis' named entity 'T-cell' named entity 'placebo control' named entity 'multivariate analysis' named entity 'myeloproliferative neoplasms' named entity 'immunosuppression' named entity 'MPN' named entity 'prophylactic measures' named entity 'prophylactic measures' named entity 'polycythemia vera' named entity 'immunosuppression' named entity 'pharmacologic treatment' named entity 'March 2020' named entity 'RUX' named entity 'MPN' named entity 'driver mutation' named entity 'anagrelide' named entity 'herpes virus' named entity 'severe infections' named entity 'tuberculosis' named entity 'meningococci' named entity 'hepatitis' named entity 'vaccines' named entity 'disease burden' named entity 'tyrosine kinase inhibitors' named entity 'JAK2' named entity 'MPN' named entity 'JAK inhibitor' named entity 'infection' named entity 'cytoreductive' named entity 'infection' named entity 'JAK inhibitors'

Attributes

Values

Creator

von Lilienfeld-Toal, Marie
Hochhaus, Andreas
Koschmieder, Steffen
Palandri, Francesca
Rachow, Tobias
Döhner, Konstanze
Auteri, Guiseppe
Brioli, Annamaria
Crodel, Carl
Ernst, Philipp
Griesshammer, Martin
Heidel, Florian
Hofmann, Verena
Isfort, Susanne
Jentsch-Ullrich, Kathleen
Jilg, Stefanie
Jost, Philipp
Kämpfe, Dietrich
Stegelmann, Frank
Wolleschak, Denise

is schema:about of

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software